Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,396 | 57 | 96.9% |
| Travel and Lodging | $28.54 | 1 | 2.0% |
| Unspecified | $16.13 | 1 | 1.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $383.17 | 20 | $0 (2022) |
| Galderma Laboratories, L.P. | $270.31 | 4 | $0 (2024) |
| Stryker Corporation | $99.71 | 4 | $0 (2022) |
| Entellus Medical, Inc. | $92.23 | 2 | $0 (2018) |
| Apyx Medical Corporation | $83.12 | 4 | $0 (2020) |
| ABBVIE INC. | $82.88 | 4 | $0 (2024) |
| AERIN MEDICAL INC. | $74.55 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $63.21 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $53.04 | 3 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $43.20 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $202.19 | 8 | AERIN MEDICAL INC. ($62.00) |
| 2023 | $125.62 | 6 | AbbVie Inc. ($39.71) |
| 2022 | $164.08 | 9 | Allergan, Inc. ($142.07) |
| 2021 | $67.70 | 3 | Allergan, Inc. ($47.43) |
| 2020 | $174.73 | 8 | Stryker Corporation ($66.81) |
| 2019 | $443.58 | 12 | Galderma Laboratories, L.P. ($211.67) |
| 2018 | $175.73 | 8 | Entellus Medical, Inc. ($72.63) |
| 2017 | $87.53 | 5 | Intersect ENT, Inc. ($28.54) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | Food and Beverage | Cash or cash equivalent | $35.56 | General |
| Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 09/06/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.23 | General |
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/03/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: EAR NOSE & THROAT | ||||||
| 06/21/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: EAR NOSE & THROAT | ||||||
| 05/10/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $18.83 | General |
| 03/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Immunology | ||||||
| 02/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/27/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INSOMNIA | ||||||
| 06/08/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $21.79 | General |
| 03/17/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $20.58 | General |
| 02/08/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $17.92 | General |
| 10/07/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/20/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $23.86 | General |
| 06/28/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/16/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/13/2022 | Stryker Corporation | CLARIFIX CRYOTHERAPY DEVICE (Device), XPRESS ENT DILATION SYSTEM, LATERA | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: INSTRUMENTS | ||||||
| 05/04/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $15.57 | General |
| 04/20/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/19/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/15/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/25/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/21/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease | Otonomy, Inc. | $16.13 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 291 | 1,690 | $83,976 | $33,495 |
| 2022 | 12 | 400 | 798 | $95,155 | $35,603 |
| 2021 | 11 | 245 | 441 | $62,051 | $23,958 |
| 2020 | 11 | 358 | 512 | $71,427 | $28,305 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 94 | $20,888 | $9,203 | 44.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 38 | 504 | $8,064 | $5,728 | 71.0% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 30 | 37 | $19,092 | $5,674 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $15,410 | $5,343 | 34.7% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 15 | 393 | $4,323 | $2,392 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $3,825 | $1,523 | 39.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 15 | 454 | $4,086 | $1,484 | 36.3% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 31 | 35 | $5,024 | $1,208 | 24.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 19 | 102 | $3,264 | $940.90 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 132 | $29,172 | $12,381 | 42.4% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 29 | 32 | $16,512 | $4,825 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $11,055 | $4,252 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 49 | $7,497 | $3,167 | 42.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 30 | 245 | $3,920 | $3,041 | 77.6% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 62 | 75 | $10,350 | $2,677 | 25.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 20 | 23 | $7,406 | $2,477 | 33.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 26 | 153 | $4,896 | $1,383 | 28.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 19 | $1,767 | $602.82 | 34.1% |
| 92557 | Comprehensive hearing and speech recognition test | Office | 2022 | 11 | 12 | $1,308 | $365.76 | 28.0% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 13 | 13 | $780.00 | $267.39 | 34.3% |
| 92567 | Test to assess middle ear function | Office | 2022 | 11 | 12 | $492.00 | $163.08 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 82 | $18,236 | $8,653 | 47.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 35 | 35 | $11,725 | $4,193 | 35.8% |
| 31231 | Diagnostic examination of nasal passages using an endoscope | Office | 2021 | 15 | 18 | $9,288 | $3,000 | 32.3% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 19 | 23 | $7,406 | $2,440 | 32.9% |
About Christopher Cote
Christopher Cote is a Otolaryngology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700880085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Cote has received a total of $1,441 in payments from pharmaceutical and medical device companies, with $202.19 received in 2024. These payments were reported across 59 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,396).
As a Medicare-enrolled provider, Cote has provided services to 1,294 Medicare beneficiaries, totaling 3,441 services with total Medicare billing of $121,361. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology/Facial Plastic Surgery
- Location Denver, CO
- Active Since 06/02/2005
- Last Updated 01/24/2024
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1700880085
Products in Payments
- BOTOX (Biological) $193.24
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $72.63
- NUCALA (Biological) $63.21
- VIVAER STYLUS (Device) $62.00
- BOTOX COSMETIC (Biological) $58.88
- CIPRODEX (Drug) $53.04
- Otovel (Drug) $43.20
- DUPIXENT (Biological) $42.49
- NONE (Device) $42.45
- NEUROMARK Device (Device) $35.56
- NAVIGATOR (Device) $35.25
- PROPEL (Device) $28.54
- CLARIFIX CRYOTHERAPY DEVICE (Device) $22.01
- XprESS Multi-Sinus Dilation System (Device) $19.60
- QUVIVIQ (Drug) $19.00
- DYSPORT (Biological) $18.83
- Xhance (Drug) $18.20
- TUDORZA PRESSAIR (Drug) $18.16
- LigaSure (Device) $17.66
- OTO-104 (Drug) $16.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Denver
Dr. David Opperman, M.d, M.D
Otolaryngology — Payments: $66,913
Dr. Owen Reichman, Md, MD
Otolaryngology — Payments: $3,527
Dr. Anya Miller, M.d, M.D
Otolaryngology — Payments: $3,375
Dr. Aniruddha Patki, Md, MD
Otolaryngology — Payments: $2,498
Dr. Christopher Oliver, Md, MD
Otolaryngology — Payments: $2,034
Dr. David Nosan, Md, MD
Otolaryngology — Payments: $1,965